covaxin news

Bharat Biotech Releases Long-Awaited Covaxin Phase 3 Data, Claims 77.8% Efficacy

Brazil Suspends $300M Covaxin Contract as Scandal Becomes Too Hot for Bolsonaro

Scientists Urge Govt to Release Covaxin Phase 3 Trial Data Before Rollout